tm logo
URZENA
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 06 Dec 2021

Last Applicant/ Owned by

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

87676271 filed on 08th Nov 2017

Registration Number

N/A

Correspondent Address

Laurence Rickles

TEVA PHARMACEUTICALS USA, Inc.

Building A

400 Interpace Parkway

Parsippany NJ 07054

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

URZENA

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and tRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

Mark Details


Serial Number

No 87676271

Mark Type

No Service/Collective Mark

Attorney Docket Number

No TEV0926TUS

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
06th Dec 2021ABANDONMENT - NO USE STATEMENT FILED
06th Dec 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10th Nov 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
10th Nov 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10th Nov 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10th Nov 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Apr 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
28th Apr 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
28th Apr 2021EXTENSION 5 GRANTED
14th Apr 2021TEAS EXTENSION RECEIVED